• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Alexandria Real Estate Equities Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    3/6/25 4:20:09 PM ET
    $ARE
    Real Estate Investment Trusts
    Real Estate
    Get the next $ARE alert in real time by email
    false 0001035443 0001035443 2025-02-28 2025-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): February 28, 2025

     

    ALEXANDRIA REAL ESTATE EQUITIES, INC.

    (Exact name of registrant as specified in its charter)

     

    Maryland   1-12993   95-4502084

    (State or other jurisdiction
    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    26 North Euclid Avenue
    Pasadena, California
     91101
    (Address of principal executive offices)  (Zip Code)

     

    Registrant’s telephone number, including area code: (626) 578-0777

     

     

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

     

    Securities registered pursuant to Section 12(b) of the Exchange Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, $.01 par value per share ARE New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On February 28, 2025, the Board of Directors (the “Board”) of Alexandria Real Estate Equities, Inc. (the “Company”) elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025, to serve until the 2025 annual meeting of stockholders of the Company and until her successor is duly elected and qualifies. In connection with Dr. Aldridge’s election, the Board increased the size of the Board from eight to nine directors. The Board also appointed Dr. Aldridge as a member of its Life Science Committee and determined that Dr. Aldridge is independent in accordance with applicable New York Stock Exchange listing standards and Securities and Exchange Commission rules. There were no arrangements or understandings between Dr. Aldridge and any other persons regarding her election to the Board. Dr. Aldridge is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     

    Dr. Aldridge was the Chief Strategy Officer of Form Bio, Inc. (“Form Bio”), the first spinout from the de-extinction and biodiversity company Colossal Biosciences Inc., from July 2022 to August 2024. At Form Bio, Dr. Aldridge led the integration of artificial intelligence (AI) and machine learning into genomic analysis and advanced therapeutics programs, such as gene therapy, biological sequence alignment, and directed evolution, to accelerate the development of safe and effective new medicines. She also oversaw the generation of vast proprietary datasets needed to train sophisticated AI models.

     

    Dr. Aldridge currently serves on the Scientific Advisory Board of Colossal Biosciences and on the board of directors of 4E Therapeutics, Inc. She sits on the Product Development Advisory Committee of the Cancer Prevention and Research Institute of Texas (CPRIT), the $6 billion state agency established to help Texans conquer cancer through research, prevention and commercialization. Dr. Aldridge is also a founding advisor for Nucleate Texas, a non-profit organization empowering the next generation of biotechnology leaders. Additionally, she participates in Duke University’s Entrepreneurial Leaders Network, which consists of a select group of Duke students and alumni who are focused on translating Duke discoveries into innovative startups, and is Past Chair of the Industrial Advisory Board of the Department of Bioengineering at The University of Texas at Dallas. In April 2023, Dr. Aldridge was named one of Forbes’ 10 women leading the synthetic biology revolution.

     

    Previously, Dr. Aldridge served as Senior Vice President, Chief of Staff and Business Operations at Taysha Gene Therapies, Inc. from July 2021 to April 2022; as Associate Vice President of Commercialization and Business Development at The University of Texas Southwestern Medical Center from April 2019 to February 2021; and as Vice President, Venture Development at Remeditex Ventures from July 2011 to April 2019.

     

    Dr. Aldridge brings more than 25 years of experience facilitating the translation of scientific discoveries into patient and commercial benefits and has leveraged her training to be a liaison between scientists and non-scientists. Her roles have included biotechnology and life science investing through venture capital; technology commercialization; improving patient outcomes through quality-based initiatives; working with disease-specific non-profits; and development and venture philanthropy.

     

    Dr. Aldridge received her Ph.D. from Duke University in the Department of Immunology and the Program in Genetics and Genomics and her Bachelor of Science degree in Biomedical Science from Texas A&M University.

     

    Upon her initial election to the Board and pursuant to the terms of the Company’s Amended and Restated 1997 Stock Award and Incentive Plan, Dr. Aldridge will receive a grant of 1,000 shares of restricted stock of the Company, which shares will vest in full on the second anniversary of the date of grant. Dr. Aldridge will also generally participate in the compensation arrangements provided to the Company’s independent directors, as described in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 3, 2024, under the caption “2023 Director Compensation Table.”

     

    The press release announcing Dr. Aldridge’s election as a director of the Company is attached hereto as Exhibit 99.1 and is filed herewith.

     

    Item 9.01Financial Statements and Exhibits

     

    (d) Exhibits

     

    99.1Press Release, dated March 6, 2025.
       
     104.1Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      ALEXANDRIA REAL ESTATE EQUITIES, INC.
         
    March 6, 2025 By: /s/ Marc E. Binda
        Marc E. Binda
        Chief Financial Officer and Treasurer

     

     

     

    Get the next $ARE alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ARE

    DatePrice TargetRatingAnalyst
    3/17/2025$100.00Hold
    Jefferies
    11/27/2024$133.00 → $121.00Overweight → Neutral
    Analyst
    11/15/2024$135.00 → $112.00Buy → Hold
    Deutsche Bank
    10/25/2024$130.00 → $125.00Outperform → Sector Perform
    RBC Capital Mkts
    9/13/2024$130.00 → $125.00Buy → Neutral
    Citigroup
    8/2/2024$136.00 → $127.00Buy → Hold
    Jefferies
    7/29/2024$151.00 → $126.00Buy → Neutral
    BofA Securities
    7/25/2024$133.00 → $126.00Outperform → In-line
    Evercore ISI
    More analyst ratings

    $ARE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alexandria Real Estate Equities, Inc. Releases 2024 Corporate Responsibility Report Highlighting Its Strategic Initiatives That Catalyze Positive Change for the Benefit of Human Health and Advance Its Sustainability Impact

      PASADENA, Calif., June 25, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, today released its 2024 Corporate Responsibility Report. Alexandria's eighth report underscores the company's groundbreaking sustainability approach and the continued execution of its consequential corporate responsibility platform, which is guided by its important mission to create and grow ecosystems to advance human health. With 10,000 known diseases and over 90% still lacking approved treatments, Alexandria's Labspace® i

      6/25/25 4:10:00 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 2Q25

      PASADENA, Calif., June 2, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.32 per common share for the second quarter of 2025. The dividend is payable on July 15, 2025 to stockholders of record on June 30, 2025. The dividend declared of $1.32 per common share is consistent with that of the preceding two quarters. Maintaining the dividend at its current level, in lieu of continuing with its recent historical growth rate averaging 4.5%, is expected to provide the company wit

      6/2/25 8:30:00 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2025 Operating and Financial Results Conference Call and Webcast on July 22, 2025

      PASADENA, Calif., May 29, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, July 22, 2025 at 2:00 p.m. Eastern Time (ET), in conjunction with the release of its second quarter 2025 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, July 21, 2025. To participate in this conference call, dial (833) 366-1125 (U.S.) or (412) 902-6738 shortly before 2:00 p.m. ET and ask the operator to join the

      5/29/25 8:30:00 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate

    $ARE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on Alexandria RE with a new price target

      Jefferies initiated coverage of Alexandria RE with a rating of Hold and set a new price target of $100.00

      3/17/25 7:22:41 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria RE downgraded by Analyst with a new price target

      Analyst downgraded Alexandria RE from Overweight to Neutral and set a new price target of $121.00 from $133.00 previously

      11/27/24 7:18:17 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria RE downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Alexandria RE from Buy to Hold and set a new price target of $112.00 from $135.00 previously

      11/15/24 7:30:20 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate

    $ARE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woronoff Michael A was granted 585 shares, increasing direct ownership by 3% to 20,107 units (SEC Form 4)

      4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)

      7/2/25 4:40:57 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Director Hash Steve was granted 379 shares, increasing direct ownership by 2% to 25,079 units (SEC Form 4)

      4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)

      7/2/25 4:39:44 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Chief Executive Officer Moglia Peter M covered exercise/tax liability with 743 shares, decreasing direct ownership by 0.26% to 283,739 units (SEC Form 4)

      4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)

      7/2/25 4:37:53 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate

    $ARE
    SEC Filings

    See more
    • Alexandria Real Estate Equities Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)

      5/15/25 4:06:39 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria Real Estate Equities Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)

      4/28/25 4:08:28 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Alexandria Real Estate Equities Inc.

      10-Q - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)

      4/28/25 4:07:00 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate

    $ARE
    Financials

    Live finance-specific insights

    See more
    • Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 2Q25

      PASADENA, Calif., June 2, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.32 per common share for the second quarter of 2025. The dividend is payable on July 15, 2025 to stockholders of record on June 30, 2025. The dividend declared of $1.32 per common share is consistent with that of the preceding two quarters. Maintaining the dividend at its current level, in lieu of continuing with its recent historical growth rate averaging 4.5%, is expected to provide the company wit

      6/2/25 8:30:00 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2025 Operating and Financial Results Conference Call and Webcast on July 22, 2025

      PASADENA, Calif., May 29, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, July 22, 2025 at 2:00 p.m. Eastern Time (ET), in conjunction with the release of its second quarter 2025 operating and financial results. Alexandria will release its operating and financial results after the market closes on Monday, July 21, 2025. To participate in this conference call, dial (833) 366-1125 (U.S.) or (412) 902-6738 shortly before 2:00 p.m. ET and ask the operator to join the

      5/29/25 8:30:00 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • Alexandria Real Estate Equities, Inc. Reports: 1Q25 Net Loss per Share - Diluted of $(0.07); and 1Q25 FFO per Share - Diluted, as Adjusted, of $2.30

      PASADENA, Calif., April 28, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2025. Key highlights Operating results 1Q25 1Q24 Total revenues: In millions $        758.2 $        769.1 Net (loss) income attributable to Alexandria's common stockholders – diluted: In millions $         (11.6) $        166.9 Per share $         (0.07) $          0.97 Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: In millions $        392.0 $        403.9 Per share $          2.30 $          2.35 A sector-leading REIT with a high-quality, diverse ten

      4/28/25 4:10:00 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate

    $ARE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Alexandria Real Estate Equities Inc. (Amendment)

      SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)

      2/13/24 4:59:02 PM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Alexandria Real Estate Equities Inc. (Amendment)

      SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)

      2/13/24 8:55:33 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Alexandria Real Estate Equities Inc. (Amendment)

      SC 13G/A - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Subject)

      1/30/24 11:21:57 AM ET
      $ARE
      Real Estate Investment Trusts
      Real Estate